Long-term exposure to ambient air pollution and risk of dementia: Results of the prospective Three-City Study.


Journal

Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270

Informations de publication

Date de publication:
03 2021
Historique:
received: 16 10 2020
revised: 07 12 2020
accepted: 30 12 2020
pubmed: 24 1 2021
medline: 27 4 2021
entrez: 23 1 2021
Statut: ppublish

Résumé

Emerging epidemiological evidence suggests a relationship between exposure to air pollution and dementia. However, most of the existing studies relied on health administrative databases for the diagnosis of dementia. In a large French population-based cohort (the 3C Study), we assessed the effects of particulate matter ≤2.5 µm (PM2.5), nitrogen dioxide (NO Participants aged ≥65 years were recruited between 1999 and 2001 and followed for 12 years. At baseline and every 2 years, dementia was suspected on the basis of the neuropsychological and neurological examination and confirmed by an independent committee of clinicians. Exposure to NO At baseline, the median age of the 7066 participants was 73.4 years, and 62% were women. The median follow-up duration was 10.0 years during which 791 participants developed dementia (n = 541 Alzheimer's disease (AD) and n = 155 vascular/mixed dementia (VaD)). The 10-year moving average of PM2.5 concentrations ranged from 14.6 to 31.3 µg/m In this large cohort of older adults, long-term PM2.5 exposure was associated with increased dementia incidence. Reducing PM2.5 emissions might lessen the burden of dementia in aging populations.

Sections du résumé

BACKGROUND
Emerging epidemiological evidence suggests a relationship between exposure to air pollution and dementia. However, most of the existing studies relied on health administrative databases for the diagnosis of dementia. In a large French population-based cohort (the 3C Study), we assessed the effects of particulate matter ≤2.5 µm (PM2.5), nitrogen dioxide (NO
METHODS
Participants aged ≥65 years were recruited between 1999 and 2001 and followed for 12 years. At baseline and every 2 years, dementia was suspected on the basis of the neuropsychological and neurological examination and confirmed by an independent committee of clinicians. Exposure to NO
RESULTS
At baseline, the median age of the 7066 participants was 73.4 years, and 62% were women. The median follow-up duration was 10.0 years during which 791 participants developed dementia (n = 541 Alzheimer's disease (AD) and n = 155 vascular/mixed dementia (VaD)). The 10-year moving average of PM2.5 concentrations ranged from 14.6 to 31.3 µg/m
CONCLUSION
In this large cohort of older adults, long-term PM2.5 exposure was associated with increased dementia incidence. Reducing PM2.5 emissions might lessen the burden of dementia in aging populations.

Identifiants

pubmed: 33484961
pii: S0160-4120(20)32330-8
doi: 10.1016/j.envint.2020.106376
pii:
doi:

Substances chimiques

Air Pollutants 0
Particulate Matter 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106376

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Marion Mortamais (M)

INM, Univ Montpellier, Inserm, Montpellier, France. Electronic address: marion.mortamais@inserm.fr.

Laure-Anne Gutierrez (LA)

INM, Univ Montpellier, Inserm, Montpellier, France.

Kees de Hoogh (K)

Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.

Jie Chen (J)

Institute for Risk Assessment Sciences (IRAS), Utrecht University, Postbrus 80125, 3508 TC Utrecht, the Netherlands.

Danielle Vienneau (D)

Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.

Isabelle Carrière (I)

INM, Univ Montpellier, Inserm, Montpellier, France.

Noémie Letellier (N)

INM, Univ Montpellier, Inserm, Montpellier, France.

Catherine Helmer (C)

INSERM, Univ Bordeaux, Bordeaux Population Health Research Centre, UMR 1219, Bordeaux, France.

Audrey Gabelle (A)

INM, Univ Montpellier, Inserm, Montpellier, France; Memory Resources and Research Centre, Department of Neurology, Gui de Chauliac Hospital, Montpellier, France.

Thibault Mura (T)

INM, Univ Montpellier, Inserm, Montpellier, France.

Jordi Sunyer (J)

Universitat Pompeu Fabra (UPF), Barcelona, Spain; ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; CIBER Epidemiologia y Salud Publica (CIBERESP), Barcelona, Spain.

Tarik Benmarhnia (T)

Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA; Scripps Institution of Oceanography, University of California, San Diego, La Jolla, CA, USA.

Bénédicte Jacquemin (B)

INSERM, Univ Rennes, EHESP, Irset Institut de Recherche en Santé, Environnement et Travail, UMR-S 1085 Rennes, France.

Claudine Berr (C)

INM, Univ Montpellier, Inserm, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH